Investors
Investor Relations
Find information about Lundbeck’s financial health, read our annual report and other investor presentations, and look up key facts, figures, and details of our share.
Latest news
- Lundbeck showcases new clinical migraine data, including long-term preventive effectiveness of Vyepti® (eptinezumab) in patients severely impacted by migraine
- Lundbeck sharpens commercial focus in line with strategy, initiates partnering in 27 markets by end-2025
- Lundbeck to present new data on bexicaserin at upcoming congress, highlighting long-term impact on seizure frequency in patients with rare epilepsy
Contact Investor Relations
Aktionærportal
Som aktionær kan du via portalen få adgang til en lang række aktionærinformationer - bl.a. kan du se din aktiebeholdning, vælge hvilken aktionærinformation du ønsker at modtage, tilmelde dig generalforsamlingen eller afgive fuldmagt.
Investor portal
As a shareholder you can access a wide range of investor information. Among other things, you can view your shareholding, choose which investor information you wish to receive, register for the AGM or appoint a proxy.